Recent therapeutic targets in diabetic nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent therapeutic targets in diabetic nephropathy

Published:2021-08-10 Issue:11 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Mohsen Marwa¹^ORCID,Elberry Ahmed A.²,Mohamed Rabea Alaa³,Abdelrahim Mohamed E. A.¹^ORCID,Hussein Raghda R. S.¹^ORCID

Affiliation:

1. Clinical Pharmacy Department Faculty of Pharmacy Beni‐Suef University Beni‐Suef Egypt

2. Clinical Pharmacology Department Faculty of Medicine Beni‐Suef University Beni‐Suef Egypt

3. Internal Medicine and Nephrology Department Faculty of Medicine Beni‐Suef University Beni‐Suef Egypt

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14650

Reference119 articles.

1. Tubulointerstitial Biomarkers for Diabetic Nephropathy

2. Molecular mechanisms of diabetic kidney disease

3. Update on Diabetic Nephropathy: Core Curriculum 2018

4. Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets

5. Advanced Glycation End Products and Diabetic Complications

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin;BMC Endocrine Disorders;2023-11-22

2. Correction to: YY1 inactivated transcription co‐regulator PGC‐1α to promote mitochondrial dysfunction of early diabetic nephropathy‐associated tubulointerstitial fibrosis;Cell Biology and Toxicology;2023-04-28

3. Study of molecular mechanisms underlying the medicinal plant Tripterygium wilfordii-derived compound celastrol in treating diabetic nephropathy based on network pharmacology and molecular docking;BIOCELL;2023

4. Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy;Frontiers in Immunology;2022-09-23

5. YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis;Cell Biology and Toxicology;2022-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3